Improving Lipid Disorders: Normalizes cholesterol and triglyceride levels, enhancing metabolic function
Over time, this can lead to: Loss of lean body mass and lower resting metabolic rate Reduced protein intake , making it harder to maintain muscle Micronutrient deficiencies , particularly vitamin D, calcium, magnesium, and B-vitamins Lower energy levels and slower recovery from illness or exercise (Mozaffarian, 2025) Gastrointestinal side effects can make the picture even more complex
Against this backdrop, orforglipron, a novel oral, non-peptide GLP-1 receptor agonist developed by Eli Lilly, has emerged as one of the most closely watched candidates in metabolic disease therapy
Treatment suitability is determined by licensed healthcare providers
And oftentimes that is doing both estrogen and progesterone and in some cases testosterone if warranted
When paired with a healthy diet and regular exercise, some studies have shown that participants can lose around 10%-15% of their weight, with other studies showing that in those who were overweight or obese, 5.9% total body weight loss at three months and 10.9% at six months was achieved